Unknown PHASE2 INTERVENTIONAL NCT03302858

A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand

Sponsor: Stephen E. Goldstone

Conditions Ain III Anal Cancer HPV-Related Squamous Cell Carcinoma HSIL, High Grade Squamous Intraepithelial Lesions Human Papilloma Virus Human Papillomavirus Infection

Interventions BARRX™ Anorectal Wand

Updated 7 times since 2017 Last updated: Oct 4, 2017 Started: Oct 31, 2017 Primary completion: Oct 31, 2019 Completion: Oct 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03302858, this PHASE2 trial focuses on Ain III and Anal Cancer and remains ongoing. Sponsored by Stephen E. Goldstone, it has been updated 7 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Nov 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Feb 2020 — Nov 2020 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Jun 2018 — Feb 2020 [monthly]

Recruiting PHASE2
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stephen E. Goldstone

Data source: Laser Surgery Care

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States